General Information of Disease (ID: DISWGWLP)

Disease Name Neisseria gonorrhoeae infection
Disease Class 1A70-1A7Z: Gonococcal infection
Disease Hierarchy
DIS01GPL: Grass pollen hypersensitivity
DISWGWLP: Neisseria gonorrhoeae infection
ICD Code
ICD-11
ICD-11: 1A7Z
ICD-10
ICD-10: A54, A54.9
Expand ICD-11
'1A7Z
Expand ICD-10
'A54; 'A54.9
Disease Identifiers
MONDO ID
MONDO_0016566
MESH ID
D008118
UMLS CUI
C0023968
MedGen ID
6132
Orphanet ID
2404
SNOMED CT ID
44250009

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 1 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Rosaramicin DMOWVU5 Approved Small molecular drug [1]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 2 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
AZD0914 DMM6G5D Phase 3 NA [2]
GSK2140944 DMSMFN2 Phase 3 NA [3]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 1 Preclinical Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Debio1453 DM8WTAZ Preclinical Small molecular drug [4]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
2 ClinicalTrials.gov (NCT03959527) Zoliflodacin in Uncomplicated Gonorrhoea. U.S. National Institutes of Health.
3 ClinicalTrials.gov (NCT04010539) A Study Evaluating Efficacy and Safety of Gepotidacin Compared With Ceftriaxone Plus Azithromycin in the Treatment of Uncomplicated Urogenital Gonorrhea. U.S. National Institutes of Health.
4 Clinical pipeline report, company report or official report of Debiopharm.